J Dev Behav Pediatr by Linares, Lourdes Oriana et al.
The Association between Cumulative Psychosocial Risk and 
Cervical HPV Infection Among Female Adolescents in a Free 
Vaccination Program
Lourdes Oriana Linares, PhD1, Viswanathan Shankar, DrPH2, Angela Diaz, MD, MPH1,3, 
Anne Nucci-Sack, MD1, Howard D. Strickler, MD, MPH2, Ken Peake, PhD1, Jocelyn Weiss, 
PhD, MPH1, Robert D. Burk, MD2,4, and Nicolas F. Schlecht, PhD2,5
1
 Department of Pediatrics, Mount Sinai Adolescent Health Center, Icahn School of Medicine at 
Mount Sinai, NY, NY, USA
2
 Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, 
NY, USA
3
 Department of Preventive Medicine, Icahn School of Medicine at Mount Sinai, NY, NY, USA
4
 Departments of Pediatrics, Microbiology & Immunology, and Obstetrics, Gynecology & Women's 
Health, Albert Einstein College of Medicine, Bronx, NY, USA
5
 Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA
Abstract
Objective—This study investigated the association of cervical Human Papillomavirus (HPV) 
infection with cumulative psychosocial risk reflecting family disadvantage, psychological distress, 
and unhealthy life style.
Methods—The sample (N=745) was comprised of sexually-active female adolescent patients 
(12-19 years), primarily ethnic minorities, enrolled in a free HPV vaccination program. Subjects 
completed questionnaires and provided cervical swabs for HPV DNA testing. Unweighted and 
weighted Principal Component Analyses (PCA) for categorical data were used to derive multi-
systemic psychosocial risk indices using nine indicators: low socioeconomic status, lack of adult 
involvement, not attending high-school/college, history of treatment for depression/anxiety, 
antisocial/delinquent behavior, number of recent sexual partners, use of alcohol, use of drugs, and 
dependency risk for alcohol/drugs. The association between cervical HPV (any-type, high risk-
types, vaccine-types) assayed by polymerase chain reaction and self-reported number of 
psychosocial risk indicators was estimated using multivariable logistic regression.
Results—Subjects had a median of three psychosocial risk indicators. Multiple logistic 
regression analyses showed associations with unweighted and weighted number of psychosocial 
indicators for HPV any-type (adjusted odds ratio [aOR]=1.1; 95% confidence interval [CI]: 
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1.0-1.2 ); with the strongest associations between weighted drug/alcohol use, drug/alcohol 
dependency risk, and antisocial/delinquent behavior and detection of HPV vaccine-types 
(aOR=1.5; 95%CI: 1.1-2.0) independent of number of recent sexual partners and vaccine dose 
(0-3).
Conclusion—Increased HPV infections including HPV vaccine-types were associated with 
greater number of psychosocial risk indicators even after controlling for demographics, sexual 
behavior, history of chlamydia, and vaccine dose.
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Human Papillomavirus (HPV) infection is the most common sexually transmitted infection 
(STI) in female adolescents, and is the central cause of cervical cancers and anogenital 
warts. Rates of both HPV infection and associated disease in the United States are especially 
high in young women from disadvantaged backgrounds.1,2 While sexual practices (e.g., 
multiple recent sexual partners) place youth at proximal risk for HPV, effective risk 
reduction for infection requires a broader understanding of the interrelated, and aggregated, 
psychosocial influences impinging on adolescent health.3-4
Known family and individual psychosocial factors cluster to produce accumulation of risk 
that negatively impact adolescent health and development.5-6 Research show that broadly 
defined psychosocial risk often precedes sexual debut in female adolescents; it occurs 
together with family disadvantage and other problem behaviors (such as alcohol and 
substance use and antisocial behavior), and acts in an additive fashion to increase risk for 
sexually transmitted infection.7,8 For example, in a National Longitudinal Study of 
Adolescent Health (ADD Health) study of 14,322 young adults between ages 18-27, STI 
prevalence increased linearly from 4.9% for 0 psychosocial factors to 14.6% for 4 or more 
(p<.001).9
Focusing on HPV infection and vaccine response in a cohort of disadvantaged female 
adolescents, we selected a multi-systemic set of individual and family factors previously 
associated with STI risky practices (multiple sexual partners), compromised emotional/
affective responses (depression and anxiety), and unhealthy behavioral lifestyles (alcohol 
use, drug use, risk for alcohol/drug dependency and antisocial/delinquent conduct).10,11 We 
included family disadvantage (including socioeconomic burden, lack of adult involvement in 
the home, and low educational attainment) because it may compromise adolescent health by 
negatively impacting on youth's emotional and behavioral pathways over the course of 
development.12 The selection of indicators was informed by work in family disadvantage,12 
multiple problem behavior theory,5 and developmental psychopathology.6 This study 
examined the association of number of psychosocial risk indicators and the detection of 
cervical HPV in disadvantaged female youth enrolled in a free vaccination program. We 
hypothesized that it is the aggregate of psychosocial risk indicators rather than the presence 
of any single indicator that assigns increased risk for HPV infection, independent of vaccine 
exposure. We also explored the relationship between number of psychosocial risk indicators 
and prevalence of the vaccine-types targeted by the quadrivalent HPV vaccine (HPV4: 
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6/11/16/18) adjusting for vaccination exposure (0-3 doses) at study enrollment. While we 
hypothesized that psychosocial drivers of infection might be independent of HPV type, and 
that the prophylactic HPV4 vaccine should offer protection regardless of psychosocial risk 
level, we sought to examine whether youth with higher psychosocial risk might have higher 
prevalence of HPV infection for vaccine types and other HPV types.
METHODS
Study Subjects
The study sample included 745 female adolescents enrolled between years 2007-2012 in an 
observational study of the real-world effect of the HPV4 vaccine.2 The cohort was 
comprised of sexually active, mostly minority (Hispanic 61%, Black or African-American 
35%, Other 4%) patients who attended the Mount Sinai Adolescent Health Center in New 
York City, which offers free integrated medical, sexual and reproductive, mental health, 
dental, optical, services, and HPV vaccination. Female adolescents were eligible to 
participate if they: i) were between 12-19 years of age at time of consent, ii) had previously 
engaged in vaginal or anal intercourse, and iii) intended to get or had already received the 
HPV4 vaccine. Potential participants who were pregnant at time of enrollment or who had 
either given birth or terminated a pregnancy within the prior 4-6 weeks were excluded.
Written informed consent, approved by the Institutional Review Board at the Icahn School 
of Medicine at Mount Sinai, was collected from all subjects prior to the baseline visit. 
Enrolled subjects completed self-reported questionnaires that contained questions about 
demographics, risk behaviors for HPV acquisition, HPV vaccination dosing status/schedule 
at the time of the baseline visit, and indicators of psychosocial functioning.
Measures
Participant characteristics and sexual practices—Participant characteristics were 
categorized based on previously published cut-points associated with risk of cervical HPV 
infection1 and HPV4 vaccine effectiveness.2,13 Self-reported measures included: age, 
ethnicity (Hispanic, Black or African-American, and Other), history of cigarette smoking, 
number of lifetime and sexual partners within the last 6 months, use of condoms and oral 
contraceptives (never used, rarely/sometimes, and most/all of the time), history of other STIs 
(Chlamydia, Trichomoniasis, Gonorrhea and Syphilis), genital warts and bacterial vaginosis, 
and HPV4 vaccine dose exposure at enrollment (unvaccinated, 1-2 doses, 3 doses).
Cervical HPV DNA detection—We tested for HPV DNA in cervical specimens collected 
on all subjects at time of enrollment as previously reported.2 Cervical cells were obtained 
using a Cytobrush placed in ThinPrep® medium (Hologic Inc, Marlborough, MA) following 
the same procedure as for Pap smears. DNA extracted from samples was tested using a well-
established PCR-based protocol.14-15 Briefly, samples were tested for over 40 HPV types 
known to infect the mucosal epithelia, including the HPV4 vaccine types (6, 11, 16 and 18) 
and other cancer-related types, using MY09/MY11 L1 consensus PCR primers, followed by 
dot-blot hybridization with biotinylated type-specific oligonucleotide probes.16 HPV DNA 
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results were categorized into three overlapping outcome groups: positive for HPV: i) any-
type, ii) high risk-types associated with cervical cancer, and iii) HPV4 vaccine-types.
Psychosocial indicators—The nine self-reported single indicators considered were: 
socioeconomic status (SES), whether an adult is living in the household (representing family 
support), whether participant attends school or college (reflecting educational attainment), 
ever treated for depression or anxiety, frequency of alcohol consumption in the past six 
months (none, <1/week, 1-2 days/week, 3-4 days/week, almost every day), use of drugs in 
the past six months (never, < once/month, 1-3 times/month, once a wk, 2-3 times/wk, 4-6 
times/wk, daily), risk for alcohol or drug dependency (based on the 6-item CRAFFT 
scale),17 antisocial/delinquent behavior (derived from the 13-item ADD Health Antisocial/
Delinquent scale),18 and number of sexual partners in the past six months.
Handling missing data—The percentage of missing data for individual measures and 
covariates are presented in Tables 1 and 2. Approximately 19% of subjects were incomplete 
information across the nine index variables, and about 2.2% had samples with insufficient 
material to detect HPV. It has been shown that analyses using complete case data produce 
biased and inefficient estimates.19,20 We therefore performed multiple imputation 
procedures to address missing information. We assumed that data was missing at random 
(MAR), meaning that the probability of missing values may depend on observed information 
but is unrelated to the specific missing value itself. We implemented a sequential regression 
multiple imputation procedure to build an appropriate and flexible imputation model. A total 
of 10 datasets were imputed for each HPV outcome, and results from the 10 runs were 
pooled for each analysis using the SAS callable “impute” module of the IVEware 
software.21
Developing the psychosocial risk indices—On the basis of above nine single 
indicators, four composite psychosocial risk indices were derived on the imputed datasets: i) 
an unweighted binary index, ii) a weighted binary index, iii) a weighted original scale index, 
and iv) a reduced weighted original scale index (based on eight indicators). The unweighted 
binary index consisted of responses to the above mentioned single indicators that were 
dichotomized as 1=high risk; 0=low risk and assigned equal weight (0-9) following an 
approach by Rutter.6 Binary categories were based on either a conceptual consideration 
(e.g., receiving a need-based public entitlement) or an established threshold cut-off (e.g., for 
the CRAFFT and ADD Health scales).17,18 Higher scores indicate higher cumulative risk. 
Table 2 depicts the definitional criteria used to assign binary risk (high or low). Since some 
indicators might contribute more than others to risk of HPV, we performed Principal 
Component Analysis (PCA) for categorical data to create the three weighted indices (ii-iv). 
This procedure allows for simultaneous quantification of binary, multinomial and continuous 
scale variables while reducing the dimensionality of the data.22 Standardized scores based 
on the first component were computed for each participant. The PCA for categorical 
variables were performed on each of the 10 imputed datasets individually for the three 
weighted outcome variables. The weights based on first PCA component for the weighted 
binary index (ii) on HPV any type were: alcohol risk dependency (0.78), drug use (0.67), 
antisocial behavior (0.61), number of sexual partners (0.42), alcohol use (0.39), history of 
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treatment for depression or anxiety (0.36), low SES (0.18), family structure (0.15), and 
education (0.07).
The PCA for the weighted original scale index (iii) gave following weights to the indicators: 
alcohol risk dependency (0.81), drug use (0.73), alcohol use (0.70), antisocial behavior 
(0.59) and lower weights for number of sexual partners (0.42), history of treatment for 
depression or anxiety (0.25), family structure (0.18), low SES (0.11), and education (0.06). 
Lastly, the reduced weighted original scale index (iv) based on eight indicators excluding 
number of sexual partners was fitted. The PCA first component estimates provided following 
weights: alcohol risk dependency (0.83), drug use (0.73), alcohol use (0.72), antisocial 
behavior (0.59), history of treatment for depression or anxiety (0.25), family structure (0.17), 
low SES (0.11), and education (0.08). The binary and original scale PCAs gave similar 
weights on the imputed datasets for high-risk HPV and vaccine types. PCA was performed 
using SPSS v 21 (IBM Corp., Armonk, NY).
Statistical Analyses
Descriptive analyses of both complete case and imputation data are presented. Mean, 
median, standard deviation, minimum and maximum statistics were used to describe 
continuous variables. Frequencies and percentages were used to describe categorical 
variables. Multiple logistic regression was used to estimate the effects of socio-demographic, 
behavioral, and psychosocial covariates in the detection of HPV any type, high-risk types, 
and HPV4 vaccine types. Potential confounding variables were screened for in unadjusted 
models (including sexual activity measures: lifetime and number of sexual partners in the 
past 6 months, and age at first sexual intercourse), and if associated with the outcomes at the 
≤20% level of significance, were included in the multivariate models along with the 
hypothesized indices. The weighted index on eight psychosocial variables had number of 
sexual partners in the past 6 months as a covariate in the final model. We present the 
summaries of the results based primarily on data obtained from the imputation analysis. The 
process of combining results from different datasets were performed using the SAS callable 
“regress” module of the IVEware software.21 All other analyses were performed using SAS 
v9.3 (SAS Institute Inc, Cary, NC).
RESULTS
Study Participants
Distribution of socio-demographic, sexual practices, and vaccination dose patient 
characteristics by both complete case and multiple imputation summaries are presented in 
Table 1. The majority of participants (61%) were 18-19 years of age and most were 
Hispanic (61%) or non-Hispanic Black or African-American (35%). Reflecting the 
enrollment criteria in this study, all participants were sexually active at the time of 
enrollment; two-thirds (63%) reported having had vaginal sex before the age of 16, and most 
(66.6%) reported having three or more lifetime male sexual partners. A third (33%) reported 
ever having Chlamydia, and almost half (41%) had ever smoked cigarettes. About half of 
participants (52%) had received all three doses of the HPV4 vaccine at the time of 
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enrollment, while 28% were completing the vaccine series (1-2 doses), and 19% had not yet 
been vaccinated (0 doses).
Psychosocial Risk Indicators
Five percent (n=40 subjects) had zero risk indicators, 21% had one, 21% had two, 23% had 
three, 15% had four, 10% had five, and 5% had six or more. Median number of risk 
indicators was three, with an interquartile range (IQR) from 1 to 4. Seventy-four percent 
experienced lifetime or current low SES, and nearly half (42%) reported having multiple 
(>1) sexual partners in the past six months. Risk of drug or alcohol dependency, as measured 
by the CRAFFT scale, was high (35%), with almost a quarter (22%) reporting having used 
illicit drugs, and 5% reported consuming alcohol in the past 6 months (refer to Table 2).
To illustrate the interrelatedness of the single psychosocial indicators, we plotted the PCA 
analysis loading weights for the nine original scale variables for the first three components 
(Figure 1). Two distinct clusters are discernible, one including alcohol/drug use/risk 
dependency measures, antisocial/delinquent behaviors and sexual activity, which were 
heavily loaded on the first principal component (‘dimension 1’), while the second and third 
dimensions differentiated these indicators from education, family structure, mental health, 
and low socioeconomic status. The medians and IQR of the standardized weighted binary 
and original scale scores were −0.22 (−0.85, 0.68) and −0.17 (−0.82, 0.66), respectively.
Association with HPV
We compared the relative increases in odds of detecting any HPV (and by risk type) for the 
four derived indices: i) unweighted score, ii) weighted score based on binary scale variables, 
iii) weighted score based on the original scale variables, and iv) weighted score based on 
eight psychosocial variables with independent adjustment for sexual activity (Table 3). 
Assuming equal weights (i.e., equal to 1) for each of the nine binary variables in the index, 
the estimated odds of detecting HPV any type increased 10% with each unit increase in the 
unweighted index score (p=0.037). In contrast, we observed stronger associations weighted 
score on original scale variables (p=0.024). The estimated odds of HPV any type infection 
increased by 19% for a unit increase in unweighted (p=0.037) and weighted psychosocial 
risk score (p=0.024). The odds of detecting a HPV4 vaccine type specifically increased 
almost 50% with each unit increase in weighted psychosocial risk score (p=0.007), which 
remained significant even after separating the proximal risk variable for HPV, number of 
sexual partners in the past 6 months, from the weighted index, and adjusting for it separately 
(p=.024).
All associations were also independent of age, ethnicity, history of chlamydia, and 
vaccination dose, which were previously shown to be associated with HPV detection in this 
population.2 Further adjusting for history of age at first sexual intercourse did not modify the 
observed associations for detection of high-risk and HPV4 vaccine types (not shown). The 
model based on the weighted eight-psychosocial-variable index revealed that the odds of 
detecting a HPV4 vaccine type increased 42% with each unit increase in the weighted score 
beyond the contribution of number of recent partners, which itself was not significant 
(p=0.350). When compared to the weighted nine-indicator original index, excluding sexual 
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activity resulted in only a 9% reduction in odds of detecting a HPV4 vaccine type with each 
unit increase in risk score.
DISCUSSION
The majority of women in the U.S. become sexually active between the ages of 15-24,23 and 
inner-city and minority women are especially at risk for STIs,24 with high prevalence rates 
seen especially for HPV despite vaccination.2 While it is known that minority adolescents 
from disadvantaged background and who engage in risky sexual practices are at increased 
risk of STIs, less is known about the association of these interrelated psychosocial factors 
taken together and HPV infection risk or vaccine response. We examined the association 
between cervical HPV-DNA detection and multi-systemic psychosocial risk based on a 
broadly defined set of psychosocial indicators including family disadvantage (low SES, no 
adult involvement in the home, not attending school or college), history of depression or 
anxiety, and risky lifestyle (use of alcohol, use of drugs, risk for alcohol or drug dependency, 
multiple sexual partners, and antisocial/delinquent behavior).
We found evidence for the association of aggregated psychosocial risk and biologic 
detection of HPV, with number and intensity of psychosocial risk indicators associated with 
increased odds of detecting cervical HPV in general, and HPV4 vaccine types in particular, 
which was independent of vaccine dose exposure and other traditional risk factors for 
cervical HPV infection. While the pattern of associations for our psychosocial indices (using 
unweighted and weighted variants) was similar for HPV any type, aggregating and assigning 
weights to the different indicators revealed which psychosocial risk indicators were 
relatively more important for predicting cervical HPV detection despite vaccination. 
Previous studies have shown a correlation between alcohol use and increases in risky sexual 
activity 8,10,11 and history of other STIs like chlamydia.8,24 Our study expands the current 
literature by showing an aggregated effect of drug and alcohol use, history of treatment for 
depression and anxiety, and family background, on the likelihood of cervical HPV infection 
in female adolescents.
Importantly, when evaluated by PCA, the strongest component weightings were observed 
with self-reported habitual alcohol use (>1 drink/week) and drug use in the past six months, 
risk of drug and alcohol dependency, and antisocial/ delinquent behaviors, which were 
distinct from education, family structure, treatment for depression/anxiety, and low SES. Not 
surprisingly, sexual activity also clustered with the alcohol and drug related risk behaviors.24 
When regressed separately onto detection of HPV4 vaccine types, the eight-variable 
weighted psychosocial index showed a significant association, independent of number 
sexual partners in the past 6 months (which was not significant) and number of vaccine 
doses (which was significant).
The finding that detection of HPV4 vaccine types was associated with increased number of 
psychosocial indicators independent of number of vaccine doses and recent sexual activity is 
intriguing and deserves further examination. In this clinic-based study, enrolled youth were 
already sexually active and at different stages of vaccination course; thus it is not possible to 
conclude whether female adolescents with high psychosocial risk would benefit more or less 
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from HPV vaccination. More likely, the finding of increased vaccine-type infection may be 
related to delayed uptake and higher likelihood of previously acquired (pre-existing) HPV4 
vaccine type infection before vaccination. Early HPV vaccination (i.e., prior to exposure) is 
important for the vaccine to be most effective, and necessary given the challenges of 
predicting onset of sexual activity. Individuals still benefit from vaccination provided that 
they have not already been infected with all HPV4 vaccine types.25,26 While vaccination is 
recommended for girls aged 11-12, and catch-up vaccination for females 13-26 years of age, 
an earlier age (e.g., 9 and 10 years) may be considered for those with high psychosocial risk 
given that upstream family disadvantage and other individual problem behaviors are often 
already present prior to sexual debut.27
The study has several limitations. It was not possible to assess individual HPV types 
associated with cancer (e.g., HPV16/18) or anogenital warts (HPV 6/11) due to the low 
prevalence of these vaccine types (N=45) to further evaluate the public health implications 
of the study. While we refer to ‘psychosocial indicators’, we recognize that these are not 
derived solely from the youth's social environment. Youth's psychological stress response to 
adversity and risky lifestyles are the result of the complex interplay between genetic 
susceptibilities and specific social context.28 Furthermore, history of child maltreatment is 
prevalent in our population,29 which has been associated with widespread consequences 
including drug and alcohol use, depression and increased risk of STIs.30 Although our 
results show that cumulative psychosocial risk is associated with HPV infection, 
independent of vaccination, it was not possible to separate biological effects from 
environmental influences in our psychosocial risk measures.
There were 19% of incomplete data. Assessment of psychosocial indicators involving 
sensitive subjects was based on self-reports. Psychological stress, which also directly or 
indirectly underlies our psychosocial risk indicators was not objectively measured in this 
study. Thus we could not assess whether stress related to psychosocial risk factors might 
have affected immune response; a hypothesis that should be further evaluated (e.g., in 
studies with vaccine type antibody titers). Future studies should consider the contribution of 
traumatic stress on proximal measures of neuro-endocrinological (i.e., cortisol) stress 
response,31 and the role of psychological distress in modulating neuro-immunological (e.g., 
antibody response) function following vaccination.32
Furthermore, while our analyses demonstrated that female adolescents with fewer 
psychosocial risk factors were less likely to be HPV positive than those with higher number 
of risk factors, it is premature to propose the utility of our indices as a risk assessment tool;7 
further studies are needed to establish a specific threshold number of risk factors above 
which HPV infection may be predicted with adequate specificity and sensitivity, and should 
consider additional contextual risk common in disadvantaged youth such as exposure to 
childhood sexual abuse and intimate partner violence.
Despite above considerations, this study suggests a detrimental role of higher multi-systemic 
psychosocial risk on cervical HPV, including for HPV4 vaccine types, and points to the need 
for broad-based approaches in disadvantaged adolescents and young adults at risk of HPV 
beyond those currently afforded in primary care settings with HPV vaccination programs. In 
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the course of delivering sexual and reproductive health care to high-risk female adolescents, 
practitioners may assess externalizing behaviors such as alcohol and drug use and antisocial/
delinquency, in addition to history of treatment for depression or anxiety, and family 
disadvantage. Broad-based assessment of these clustered psychosocial risk indicators may 
expand counseling about healthy choices involving not only sexual decision making, but also 
psychological well-being, and healthy lifestyles. Furthermore, the early identification of 
girls at most risk for HPV infection may inform joint decisions by the practitioner, the 
youth, and her family about the appropriateness of initiating prophylactic HPV vaccination 
at an earlier age (within the range of approved ages 9-26 years) than currently 
recommended.
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Figure 1. 
Principal Component Analysis plot (3 components) of the nine psychosocial indicators 
associated with cervical HPV detection
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